Valentina Restelli

Via Mario Negri 2
Milan, 20156, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma.

Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma.

Journal: Cancers

Published: February 21, 2020

Structure-Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR.

Structure-Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR.

Journal: ChemMedChem

Published: October 20, 2018

DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas.

DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas.

Journal: Molecular cancer therapeutics

Published: August 13, 2018

Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking.

Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking.

Journal: Future medicinal chemistry

Published: May 17, 2018

BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance.

BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance.

Journal: ESMO open

Published: April 25, 2018

Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines.

Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines.

Journal: Targeted oncology

Published: February 15, 2018

Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation.

Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation.

Journal: British journal of haematology

Published: December 28, 2016

Probing an Allosteric Pocket of CDK2 with Small Molecules.

Probing an Allosteric Pocket of CDK2 with Small Molecules.

Journal: ChemMedChem

Published: September 19, 2016

Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.

Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.

Journal: Oncotarget

Published: June 17, 2015

Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma.

Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma.

Journal: Oncotarget

Published: August 04, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026